Tumor cells evade adaptive immunity by a variety of mechanisms, including selection of variants that are resistant to specific cytotoxic T lymphocyte (CTL) pressure. Recently, we have reported that the reorganization of the actin cytoskeleton can be used by tumor cells as a strategy to promote their resistance to CTL-mediated lysis. In this study, we further examined the functional features of a CTL-resistant tumor variant and investigated the relationship between cytoskeleton alteration, the acquisition of tumor resistance to CTL-induced cell death, Rho-GTPases, and focal adhesion kinase (FAK) pathways. Our data indicate that although the resistant cells do not display an increased migratory potential, an alteration of adhesion to the extracellular matrix was observed. When Rho-GTPases were activated in cells by the bacterial CNF1 (cytotoxic necrotizing factor 1), striking changes in the cell morphology, including actin cytoskeleton, focal adhesions, and membrane extensions, were observed. More importantly, such activation also resulted in a significant attenuation of resistance to CTL-induced cell death. Furthermore, we demonstrate that FAK signaling pathways were constitutively defective in the resistant cells. Silencing of FAK in the sensitive target cells resulted in the inhibition of immune synapse formation with specific CTLs and their subsequent lysis. Expression of the FAK mutant (Y397F) resulted in an inhibition of IGR-Heu cell adhesion and of their susceptibility to specific lysis. These results suggest that FAK activation plays a role in the control of tumor cell susceptibility to CTLmediated lysis.
Cytotoxic T lymphocytes (CTLs) 3 are important effector cells in tumor rejection and have been described to play a crucial role in host defense against malignancies in both mouse and human (1) . It has been reported that although tumor-specific T cell responses prevent tumor cell growth, they may also select resistant variants in vivo, such as tumor antigen-negative variants (2) . Accumulating evidence indicates that tumor cells play a crucial role in the control of immune protection (3) and possess many overlapping mechanisms to maintain their functional disorder and evasion. In this regard, it has been suggested that tumor cell growth in vivo is not only influenced by CTLtumor cell recognition but also by tumor susceptibility to cellmediated death. Several mechanisms have been associated with the acquisition of tumor resistance to cell-mediated cytotoxicity. Recently, we have identified an additional mechanism that involved alteration of tumor cell actin cytoskeleton (4), confirming that changes in the expression of specific structural components of the actin cytoskeleton can affect tumor susceptibility to cytotoxic treatments (5) and that the cytoskeleton plays a critical role in various cellular processes. In this respect, it can no longer be considered as only a structural framework playing a role in cell shape, adhesion, motility, exocytosis, and endocytosis.
It is well established that cytoskeleton-dependent activities are governed by Rho-GTPases, a family of regulatory molecules composed of three different subfamilies, Rho, Rac, and Cdc42, that coordinate multiple signaling pathways and the transcription of specific target genes. Rho proteins act to fine-tune the cell, reshaping it during cell polarization, movement, differentiation, and phagocytosis (6, 7) .
Focal adhesions are integrin-mediated points of contact between the cytoskeleton and the extracellular matrix. Coordinated assembly and disassembly of focal adhesions as well as intracellular signaling from these sites modulate cell adhesion, migration, proliferation, differentiation, and survival in response to different stimuli (8, 9) . FAK (gene name ptk2) is a central node in the signaling network emanating from focal adhesions (10) . This protein is recruited to sites of integrin clustering via interactions of its C-terminal domain with integrinassociated proteins. Although the precise mechanisms by which cell-surface receptors, such as integrins, initiate FAK activation are not very well understood, evidence has been provided indicating that integrin or growth factor activation induces FAK to autophosphorylate on Tyr-397 (11) . Phosphorylation on Tyr-397 creates a binding site for Src kinases (26) . The resulting activated FAK-Src complex phosphorylates other FAK tyrosine residues (26) and substrates, including paxillin (12) and p130 Cas (13) , and affects reorganization of the actin cytoskeleton via Rho family GTPases (10) . Despite the recent advances in the understanding of the complex interplay between GTPases and FAK as well as their potential role in the regulation of the actin cytoskeleton, their putative implication in the regulation of the anti-tumor cytotoxic response remains unknown. Our results suggest that besides actin content (4) that might act as a molecular switch in the control of tumor susceptibility to CTL killing, the activation of FAK may orchestrate a dynamic cross-talk between actin filaments and signaling pathways that play a key role in the control of tumor target sensitivity to CTL-induced cell death.
EXPERIMENTAL PROCEDURES
Toxins-Cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli was used as a GST fusion protein and purified as described previously (14) . After dialysis against PBS, CNF1 purification was checked by SDS-PAGE.
Tumor Cell Lines and CTL Clone-The non-small cell lung carcinoma tumor cell line, IGR-Heu, was derived from a largecell carcinoma of the lung, as described (15) , and cultured in DMEM/F-12 medium containing 10% heat-inactivated fetal calf serum, 1% Ultroser G (Invitrogen), 1% sodium pyruvate (Invitrogen). The Heu161 CTL clone was isolated from autologous tumor-infiltrating lymphocytes, as described (15) . The resistant cell line to CTL lysis, IGR-HeuR, was derived from IGR-Heu and was established after 3 months of co-culture with the autologous CTLs. The cell line was then cloned by limiting dilution, and several clones, including IGR-HeuR8, were isolated (4) .
DNA Constructs and Cell Transfections-The cDNAs encoding the FAK mutants (Y397F and Y925F) in the pcDNA3 expression vector were kindly provided by Dr. K. Yamada (National Institutes of Health, Bethesda). In total, 10 6 cells were plated in 10-cm 2 dishes. Transient transfection was carried out the next day using the Lipofectamine 2000 transfection reagent (Invitrogen) and 4 g of plasmid DNA according to the manufacturer's instructions. 48 h later, the cells were used in experiments.
RNA Interference-Gene silencing of FAK expression was performed using sequence-specific siRNA (Qiagen, Inc., Valencia, CA). Briefly, cells were transfected by electroporation with 50 nM of short interfering RNA in a Gene Pulser Xcell Electroporation System (Bio-Rad, 300 V, 500 microfarads) and then allowed to grow for 72 h. An siRNA targeting enhanced green fluorescent protein was used as a negative control (5Ј-GCAAGCUGACCCUGAAGUUCAU-3Ј). All sequences were evaluated for gene specificity using the Blast Program from the National Institutes of Health.
Cytolytic Activity Assay-As described previously (16) , the cytotoxic activity of the CTL clone was measured by a conventional 4-h 51 Cr-release assay by using triplicate cultures in round-bottomed 96-well plates. The percentage of specific cytotoxicity was calculated conventionally.
Pulldown Assay and Immunoblotting-Briefly, cells were scraped, chilled on ice, and lysed in ice-cold buffer containing 1% Triton X-100, 25 mM HEPES, pH 7.3, 500 mM NaCl, 10% glycerol, 10 mM MgCl 2 , 0.1 mM phenylmethylsulfonyl fluoride, 4 g⅐ml Ϫ1 aprotinin, 1 g⅐ml Ϫ1 leupeptin, and 1 g⅐ml Ϫ1 pepstatin. Lysates were centrifuged for 20 min at 13,000 ϫ g. Active (GTP-bound) forms of RhoA, Rac1, or Cdc42 were captured by pulldown assay and quantified by Western blotting of the precipitated material, as described previously (17) . Rho-GTP was captured using GST-Rho binding domain rhotekin; Rac-GTP and Cdc42-GTP were both captured using GST-Cdc42/Racinteractive binding domain (CRIB) PAK. The beads were washed four times in lysis buffer (containing 150 mM NaCl) and boiled in 25 l of SDS-PAGE lysis buffer containing reducing agents. Proteins were resolved on 12% SDS-PAGE, transferred onto nitrocellulose membranes, and immunoblotted. Activated Rho-GTPases were revealed by immunoblotting using specific anti-Rac and anti-Cdc42 antibodies (BD Transduction Laboratories) and an anti-RhoA antibody described previously by Lang et al. (18) . The labeling was visualized using peroxidase-conjugated secondary antibodies and by enhanced chemiluminescence (ECL kit, Amersham Biosciences).
Western Blotting-Adherent tumor cells were washed in PBS and then solubilized on ice in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 25 M leupeptin, 5 mM benzamidine, 1 M pepstatin, 25 M aprotinin, 50 mM sodium ␤-glycerophosphate, 20 mM sodium pyrophosphate, 0.5 mM dithiothreitol). After centrifugation, lysates (50 g per lane) were resolved by SDS-PAGE and transferred onto nitrocellulose membranes. After incubation in blocking buffer, the membranes were probed overnight at 4°C with anti-FAK monoclonal antibody (diluted 1:1000; Upstate Biotechnologies, Lake Placid, NY) or anti-phospho-FAK (diluted 1:500; Upstate Biotechnologies). The labeling was visualized using peroxidaseconjugated secondary antibodies and by enhanced chemiluminescence (ECL kit, Amersham Biosciences).
Cell Adhesion Assay-Cellular adhesion to extracellular matrix proteins was quantified by plating cells on fibronectin (Sigma), Matrigel TM (BD Biosciences), and type I and IV collagens (BD Biosciences). Nunc Immuno-Plate MaxiSorp TM plates (Nunc, Roskilde, Denmark) were coated with 5 g/ml fibronectin, 3 g/ml collagen I or collagen IV overnight at 4°C, and 0.3 mg/ml Matrigel TM for 20 min at 37°C, then blocked with DMEM/F-12 ϩ 2% bovine serum albumin for 30 min at 37°C, and washed with PBS. At 80 -90% confluency, tumor cells were harvested with 0.1 mM EDTA, and 4 ϫ 10 4 cells/well were seeded in serum-free DMEM/F-12 medium for 5-90 min at 37°C. Nonadherent cells were removed by gentle washing of the wells twice with PBS. Remaining attached cells were quantified by adding 100 l of culture medium and 50 l of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (0.25 mg/ml) as described previously (19) .
Confocal Microscopy-Tumor cells alone or co-cultured with autologous CTL at a 1:2 target/effector ratio were plated on glass coverslips or poly-L-lysine slides (Sigma) (for conjugate formation study), fixed with 3% formaldehyde/PBS for 10 min, permeabilized with 0.1% Triton X-100/PBS for 5 min, followed by blocking with 1% bovine serum albumin/PBS for 20 min. The fixed cells were stained with rhodamine-phalloidin (Molecular Probes) for actin staining and/or with an anti-vinculin antibody (Sigma) followed by Alexa-488 secondary antibody (Molecular Probes). Coverslips or poly-L-lysine slides (Sigma) were mounted with Vectashield (Vector Laboratories, Burlingame, CA) and analyzed the following day by a Zeiss laser scanning confocal microscope (LSM-510, Jena, Germany). Z-projection of slices was performed using LSM Image Examiner software (Zeiss).
RESULTS

Resistance to CTL-mediated Lysis Is Associated with a Major Cell Adhesion Defect to the Extracellular Matrix
Compounds-The human non-small cell lung carcinoma cell line IGR-Heu and the autologous CTL clone Heu161 (CD3 ϩ , CD8 ϩ , CD4 Ϫ , and CD28 Ϫ ) were described previously (15) . As shown in Fig. 1A , Heu161 displays a strong cytotoxic activity against IGR-Heu autologous cells and only a weak activity toward its derivative IGR-HeuR8-resistant variant cells. To investigate the possible relationship between the acquisition of resistance to CTL-mediated cytotoxicity and the cell adhesion capacity, adhesion assays to extracellular matrix compounds were performed. As shown in Fig. 1B , IGR-HeuR8-resistant cells displayed a reduced adhesion to type I and IV collagens as well as to Matrigel TM . Adhesion of IGR-Heu cells to fibronectin was very weak and abolished for IGR-HeuR8. To determine whether the defect in IGRHeuR8 cell adhesion to the extracellular matrix was associated with differences in the surface expression of adhesion molecules, the expression of the integrin subunit ␤ 1 , a known receptor for collagen I and IV (20) , as well as the various extracellular matrix integrin receptors ␣ v ␤6, ␣ v ␤5, and ␣ v ␤3 was investigated. No difference in the integrin repertoire between IGR-Heu and IGR-HeuR8 cells was observed (data not shown), suggesting that a defect in integrin downstream signaling pathways may contribute to IGR-HeuR8 cell adhesion defect rather than differences in integrin expression levels.
Activation of Rho-GTPases Induces Morphological Changes in IGR-HeuR8-resistant Cells and
Increases Their Adhesion to Type I and IV Collagens-Integrins are receptors that mediate dynamic linkage between extracellular matrix molecules and the actin cytoskeleton (21). The profound reorganization of the actin cytoskeleton observed in IGR-HeuR8 cells (4) strongly suggests that proteins implicated in the actin cytoskeleton dynamics could be involved in the IGR-HeuR8 cell adhesion defect. Accumulating evidence points to the notion that actin cytoskeleton dynamics is regulated by a complex interplay of the small GTPase proteins Rac, Rho, and Cdc42 (9) . Therefore, we asked whether the alteration in cytoskeleton organization in IGR-HeuR8 cells resulted from a deregulation of the activity of small GTP-binding proteins. We focused on the Rho family in particular, because these regulatory molecules are involved in the control of the actin cytoskeleton organization and dynamics (22). To investigate the functional role of Rhodependent pathways in cell adhesion, cells were treated with the CNF1 (cytotoxic necrotizing factor1), a bacterial toxin that is able to directly activate the Rho-GTPases (23) (24) (25) . The activated (GTP-bound) form of RhoA, Rac1, and Cdc42 was assessed by a GST pulldown experiment as described under "Experimental Procedures." As shown in Fig. 2A, CNF1 treatment of IGR-Heu and IGR-HeuR8 cells similarly increased the activated form of RhoA, Rac1, and Cdc42. In addition, the results shown in this figure indicate a significant and selective Rac1 degradation in CNF1-treated IGR-Heu sensitive cells.
Given the ability of Rho-GTPases to control the actin cytoskeleton organization, we asked whether the modulation of these regulatory proteins by CNF1 could restore actin organization in IGR-HeuR8. As shown in Fig. 2B , CNF1 induced morphological changes of IGR-HeuR8 from round to spread cells, which were accompanied by important actin cytoskeleton enrichment and the formation of several adhesive contacts. Immunofluorescence analysis using anti-vinculin antibody clearly demonstrated that IGR-HeuR8 cells lack the adhesion contacts corresponding to focal adhesions that are observed in IGR-Heu cells. CNF1 treatment did not have any impact on IGR-HeuN morphology. The morphological changes observed in IGR-HeuR8 cells upon CNF1 treatment were dependent on Rho-GTPases as treatment of the cells with C3 exoenzyme, a known inhibitor of RhoA, RhoB, and RhoC proteins, NOVEMBER 14, 2008 • VOLUME 283 • NUMBER 46
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suppressed this effect (Fig. 2C) . Although C3 induced an alteration of IGR-Heu morphology (cytosol retraction and long protrusions), it had no effect on IGR-Heu cells in the presence of CNF1. We next investigated whether Rho-GTPase activation was able to restore IGRHeuR8 cell adhesion defects. As shown in Fig. 2D , whereas treatment of IGR-HeuR8 cells with CNF1 resulted in an increase in cell adhesion to the type I and type IV collagens, the defect of cell adhesion to fibronectin and Matrigel TM remained unaffected.
Activation of Rho-GTPases Attenuates IGR-Heu Resistance to CTLmediated Cytotoxicity-Based on
the assumption that such a morphological remodeling observed following CNF1 exposure could have a consequence on tumor cell susceptibility to CTL-mediated lysis, we performed a cytotoxic assay using CNF1-treated IGR-HeuR8 cells. For this purpose, target cells exposed to the CNF1 toxin for 2 or 18 h were tested for their susceptibility to killing by the CTL clone. As shown in Fig. 3 , whereas no effect was observed after 2 h of IGR-HeuR8 incubation with CNF1, a significant increase in IGR-HeuR8 killing was observed following 18 h of incubation. These results provide evidence that activation of RhoGTPases is sufficient to partially restore CTL-mediated cytotoxicity of IGR-HeuR8 cells.
Tumor Cell Resistance to CTLmediated Lysis Correlates with a FAK Activation Default-FAK plays a prominent role in multiple aspects of cell adhesion processes. It has been suggested that FAK is a critical protein, which participates in several cell adhesion signaling pathways to coordinate appropriate biological responses (26) . Because the activation of Rho-GTPases induced the formation of focal contacts in IGR-HeuR8 cells, we compared the expression level and the phosphorylation status of FAK in sensitive IGR-Heu and its derivative-resistant IGR-HeuR8 cells untreated or treated with CNF1. Data shown in A, pulldown analysis of activated (GTP-bound) RhoA, Rac1, and Cdc42 in IGR-Heu and IGR-HeuR8 cells untreated (Ϫ) or treated (ϩ) with CNF1 (0.5 g/ml) for 0, 2, 6, 12, and 18 h. Cells were then lysed and 500 g of total lysate were used to precipitate active GTPases using GST-Rho binding domain-rhotekin for RhoA and GST-CRIB-PAK for Rac1 and Cdc42. Active proteins were eluted from the beads by heating and analyzed by Western blotting using the specific antibodies. For each time point, 40 g of total lysate was run to control the amount of GTPases before precipitation. B, effect of CNF1 on actin cytoskeleton organization and focal contacts. Tumor cells were cultured on coverslips in the presence of CNF1 (0.5 g/ml) during 18 h, washed, fixed in 3% paraformaldehyde, and permeabilized with 0.1% Triton X-100. Cells were double-labeled with rhodamine-phalloidin to monitor the actin cytoskeleton (red) and with anti-vinculin antibody followed by secondary antibody to monitor focal adhesion contacts (green). The right panel show merged image of actin and vinculin. C, effect of C3 exoenzyme on CNF1-induced morphological changes. Cells cultured on coverslips were pretreated with C3 exoenzyme (50 g/ml) for 2 h, and then CNF1 (0.5 g/ml) was added up to 14 h. Cells were labeled for vinculin visualization as described in B. D, adhesion of IGR-HeuR8 cells treated for 18 h or not with CNF1 (0.5 g/ml) as a function of time on type I and IV collagen, Matrigel TM , and fibronectin. Each bar is the mean of three independent experiments Ϯ S.D. Fig. 4 indicate that the expression level of FAK was similar in both cell types. Next, using anti-phospho-FAK specific antibodies, we analyzed the phosphorylation of Tyr-397 and Tyr-925, two main tyrosines known to be phosphorylated during FAK activation (26) . As shown in Fig. 4 , phosphorylation of FAK on Tyr-397 and Tyr-925 was strongly decreased in IGRHeuR8 cells compared with IGR-Heu cells. Treatment of IGRHeuR8 during 6, 12, and 18 h with CNF1 induced an increase in the phosphorylation of FAK on Tyr-925 and Tyr-397 in these cells. This result demonstrates that the constitutive level of activated FAK was significantly reduced in IGR-HeuR8 compared with its level in the sensitive cells IGR-Heu. It also strongly suggests that the phosphorylation of FAK on Tyr-397 and Tyr-925 may play a role in the control of tumoral cell resistance to CTL-mediated lysis.
Involvement of FAK in the Control of Specific Tumor Target Lysis-To further explore the role of FAK in regulating target cell susceptibility to CTL-mediated lysis, we inhibited its expression in IGR-Heu cells using two different specific siRNAs designed to target FAK. As shown in Fig. 5A , both siRNA were able to completely abolish the expression of FAK in IGR-Heu cells compared with control green fluorescent protein siRNA. The ability of control cells and FAK-siRNA-transfected cells to form the immunological synapse with autologous CTL was next analyzed as described under "Experimental Procedures." As shown in Fig. 5B , silencing of FAK in IGR-Heu cells dramatically suppressed the formation of immunological synapse with Heu161 CTL. The few synapses formed are characterized by a slight actin accumulation in the synaptic contact that was reminiscent of those formed by IGR-HeuR8 (4). We next examined the ability of CTL to kill IGR-Heu cells transfected with control and FAK-siRNA. The results shown in Fig. 5C clearly indicate a remarkable decrease (50%) in the susceptibility of FAK-siRNAtransfected IGR-Heu cells to CTL-mediated lysis. It points to a role of FAK in the regulation of tumoral susceptibility to CTLmediated lysis.
Expression of FAK Mutant (Y397F) in IGR-Heu-sensitive Cells Decreases Their Adhesion and Susceptibility to CTL-induced
Cell Death-To examine the role of tyrosine phosphorylation on residues Tyr-397 and Tyr-925 of FAK in the control of IGR-Heu cell adhesion and susceptibility to lysis, we studied the cellular effects of the overexpression of two different FAK mutants, Y397F and Y925F. IGR-Heu cells were transfected with these mutants as described under "Experimental Procedures." As shown in Fig. 6A , the expression of FAK-Y397F and FAK-Y925F decreased the phosphorylation level of FAK, respectively, in Tyr-397 and Tyr-925 in transfected IGR-Heu cells. Investigation of the adhesion potential of IGR-Heu cells revealed a significant and time-dependent increased level of cell adhesion to fibronectin, collagen I, collagen IV, and Matrigel TM , whereas IGR-HeuR8 cells displayed only a slight adhesion increase. Interestingly, Y397F mutant FAK significantly inhibited cell adhesion at all times tested compared with nontransfected control cells and resulted in an adhesion level comparable with the one observed with IGR-HeuR8 cells. In contrast, no apparent differences in cell adhesion to the various extracellular matrix proteins or to Matrigel TM were observed in Y925F mutant-transfected IGR-Heu cells.
To examine the role of Y397F and Y925F mutants of FAK in the control of IGR-Heu cell susceptibility to the autologous CTL clone Heu-161, the lysis of FAK mutant-transfected cells was tested. As shown in Fig. 6B , a significant decreased lysis (50% inhibition) in Y397F-FAK-transfected IGR-Heu cells was observed, whereas no effect was detected in cells expressing the FAK-Y925F mutant. This suggests a critical role of Tyr-397 in FAK-associated regulation of IGR-Heu adhesion and susceptibility to specific lysis. 
DISCUSSION
The ability of cancer cells to evade immune surveillance and resist immunotherapy raises a fundamental question of how tumor cells survive in the presence of a competent immune system. Studies to address this question have primarily focused on mechanisms by which tumor cells avoid recognition by or induce tolerance in the immune system. However, little is known about the possibility that cancer cells might also acquire an intrinsic ability to resist to killing by immune effectors. We have recently reported that cancer cells enhance their ability to withstand an attack by cytotoxic immune effector cells via cytoskeleton remodeling (4) . This further suggests that immunoediting of tumors results in cellular reprogramming that may be accompanied by alterations in tumor characteristics, including morphological changes. Here we investigated the putative signaling pathways that may be associated with the resistance phenotype and assigned a new role for FAK in the cross-talk between killer cells and their targets.
Several studies on actin-associated proteins demonstrate that changes in the expression of specific structural component of the actin cytoskeleton can contribute to tumorigenesis (27) . Our data indicate that the acquisition of tumor resistance to CTL-induced cell death and the subsequent remodeling of the cytoskeleton were not accompanied with an in vitro increased migratory potential (data not shown). Interestingly, we found that such resistance correlates with a major adhesion defect to extracellular matrix compounds independently of integrin expression and ␤1 functionality. Indeed, blocking ␤1 integrin had no effect on tumoral susceptibility to lysis, ruling out its involvement in the tumor resistance to CTLs (data not shown).
It is well established that actin dynamics is regulated by a complex interplay of the small GTPase proteins Rac, Rho, and Cdc42 (28), coordinating multiple signaling pathways and transcription of specific target genes. In this respect, we investigated in our model the possible implication of Rho family proteins (RhoA, Rac1, and Cdc42) controlling the actin cytoskeleton organization and dynamics. For this purpose, we used CNF1, a toxin activating Rho-GTPases (23) (24) (25) . We could demonstrate that such a compound increased the level of polymerized actin and the formation of focal adhesions in the resistant variant clone. This is consistent with data from other previous reports using distinct cellular models (29) . Our data also demonstrated that CNF1 treatment of resistant IGR-HeuR8 restored the parental morphology and attenuated the cell resistance to CTL-mediated killing. This confirms the multifunctional role of the Rho family and suggests that GTPases are not affecting only the morphological events but may interfere with the survival phenotype and the subsequent target killing by CTLs.
FAK is an important tyrosine kinase that regulates the organization of the actin cytoskeleton and modulates cell adhesion and proliferation. Using Western blot analysis, we could demonstrate that the acquisition of tumor cell resistance resulted in a defect in the constitutive FAK activation in the tumor-resistant variant IGR-HeuR8. Such a defect could result from the disorganization of the actin cytoskeleton as previously shown by Schaller and Parsons (30) . Moreover, it has been reported that expression of Rnd3 (RhoE) protein, which counteracts Rho signaling, interferes with actin cytoskeletal organization and focal adhesion turnover (31, 32) , reinforcing the hypothesis of a Rho deregulation as a possible mechanism associated with an altered FAK activation. Given the involvement of Eph/Ephrin family of proteins in the regulation of FAK activity and expression and because EphrinA1 was found to be overexpressed in the resistant variant (4), it remains undetermined whether it may serve as a critical negative regulator of FAK in our experimental system.
In the course of these studies, we found that CNF1 treatment of the IGR-HeuR8 variant resulted in the phosphorylation of Immunoblotting with anti-actin antibody was performed to confirm equal loading of proteins. B, suppression of immunological synapse formation (arrow) between Heu161 and FAK siRNA IGR-Heu-transfected cells. Control and FAK siRNA-transfected cells described in A were plated in the presence of CTL on poly-L-lysine-coated slides for 30 min at a 2:1 effector/target ratio. Cells were fixed, permeabilized, and then stained with rhodamine phalloidin to visualize actin cytoskeleton (red). C, silencing of FAK impaired tumoral susceptibility to CTLmediated lysis. 51 Cr-Labeled control and FAK siRNA IGR-Heu-transfected cells were incubated at 37°C with CTLs at different ratios. After 4 h, the supernatants were collected and analyzed by gamma counter as described under "Experimental Procedures." reduce cancer proliferation, migration, and invasion (37, 46, 47) . The investigation of FAK-related signaling should therefore provide new insights into how FAK exerts a dual effect within tumor cells by promoting pro-or anti-apoptotic pathways.
Together our results are consistent with a model whereby the alteration of cytoskeleton in resistant tumor variant and the changes in cell plasticity interfere with cell adhesion and FAK/ Rho-dependent pathways. Our findings point to the existence of a relationship between the acquisition of tumor resistance to CTL-induced killing and FAK pathway that appears to be involved in effector/target conjugate formation and the subsequent tumor cell death.
